Current concepts underlying benefits of exercise training in congestive heart failure patients.

Maqsood Elahi, Mohsin Mahmood, Ahmad Shahbaz, Naveed Malick, Jawad Sajid, Sanjay Asopa, Bashir M Matata
Author Information
  1. Maqsood Elahi: Wessex Cardiothoracic Centre, General/ BUPA, Chalybeate Close, Southampton, SO16 6UY, United Kingdom.

Abstract

The pathophysiology of several conditions including heart failure is partly attributable to a failure of the cell energy metabolism. Studies have shown that exercise training (ET) improves quality of life (QOL) and is beneficial in terms of reduction of symptoms, mortality and duration of hospitalization. Increasingly, ET is now achieving acceptance as complimentary therapy in addition to routine clinical practice in patients with chronic heart failure (CHF). However, the mechanisms underlying the beneficial effects of ET are far less understood and need further evaluation. Evidence suggests that while CHF induces generalized metabolic energy depletion, ET largely enhances the overall function of the heart muscle. Hence, research efforts are now aiming to uncover why ET is beneficial as a complimentary treatment of CHF in the context of improving endothelial function and coronary perfusion, decreasing peripheral resistance, induction of cardiac and skeletal muscle cells remodeling, increasing oxygen uptake, substrate oxidation, and resistance to fatigue. Here we discuss the current evidence that suggest that there are beneficial effects of ET on cardiac and skeletal muscle cells oxidative metabolism and intracellular energy transfer in patients with CHF.

Keywords

References

  1. Med Sci Sports Exerc. 1999 Jul;31(7):987-97 [PMID: 10416560]
  2. Biochim Biophys Acta. 2007 Jan;1772(1):5-14 [PMID: 17045464]
  3. J Child Neurol. 2009 Oct;24(10):1316-20 [PMID: 19535813]
  4. Am Heart J. 2004 Jan;147(1):100-5 [PMID: 14691426]
  5. Am J Cardiol. 2004 Jan 15;93(2):221-5 [PMID: 14715354]
  6. J Am Coll Cardiol. 2007 Dec 11;50(24):2355-6; author reply 2356 [PMID: 18068048]
  7. J Am Coll Cardiol. 2007 Jun 19;49(24):2337-40 [PMID: 17572249]
  8. Am J Cardiol. 2001 Oct 1;88(7):805-8 [PMID: 11589856]
  9. Am Heart J. 1999 Aug;138(2 Pt 1):233-40 [PMID: 10426833]
  10. Hum Mol Genet. 2009 Jul 15;18(14):2670-82 [PMID: 19417006]
  11. Eur Heart J. 1999 Jul;20(13):946-53 [PMID: 10361046]
  12. Am Heart J. 2001 Jul;142(1):160-6 [PMID: 11431673]
  13. J Card Fail. 2000 Mar;6(1):47-55 [PMID: 10746819]
  14. Circ Res. 2004 Jul 23;95(2):135-45 [PMID: 15271865]
  15. Circ Res. 2001 Jul 6;89(1):E1-7 [PMID: 11440984]
  16. J Card Fail. 2007 Mar;13(2):79-85 [PMID: 17395046]
  17. Prog Cardiovasc Nurs. 2005 Winter;20(1):17-23 [PMID: 15785166]
  18. J Biol Chem. 2009 Oct 2;284(40):27577-86 [PMID: 19674972]
  19. Am J Med. 2004 May 15;116(10):693-706 [PMID: 15121496]
  20. Am J Physiol Regul Integr Comp Physiol. 2009 Dec;297(6):R1761-8 [PMID: 19793954]
  21. J Card Fail. 2007 May;13(4):294-303 [PMID: 17517350]
  22. Circulation. 2003 Mar 4;107(8):1210-25 [PMID: 12615804]
  23. Europace. 2006 Mar;8(3):157-60 [PMID: 16627431]
  24. J Cell Sci. 2009 Dec 15;122(Pt 24):4516-25 [PMID: 19920079]
  25. Arch Biochem Biophys. 2006 Jun 1;450(1):78-88 [PMID: 16620764]
  26. Exp Clin Transplant. 2006 Jun;4(1):445-50 [PMID: 16827641]
  27. J Card Fail. 2004 Feb;10(1):21-30 [PMID: 14966771]
  28. Clin Rehabil. 2009 Mar;23(3):207-16 [PMID: 19218296]
  29. Online J Knowl Synth Nurs. 2000 Feb 9;7:5 [PMID: 12489037]
  30. J Exp Biol. 2003 Jun;206(Pt 12):2039-47 [PMID: 12756286]
  31. J Card Fail. 2009 Nov;15(9):763-9 [PMID: 19879462]
  32. J Am Coll Cardiol. 2007 Jun 19;49(24):2329-36 [PMID: 17572248]
  33. Eur Heart J. 1999 Aug;20(16):1191-200 [PMID: 10448028]
  34. Cardiovasc Res. 2004 Feb 1;61(2):218-26 [PMID: 14736538]
  35. J Card Fail. 1999 Sep;5(3):188-94 [PMID: 10496191]
  36. Cardiovasc Res. 2009 Feb 15;81(3):449-56 [PMID: 18854381]
  37. Am J Physiol Regul Integr Comp Physiol. 2009 Jul;297(1):R26-33 [PMID: 19339678]
  38. Circulation. 2002 Jul 16;106(3):362-7 [PMID: 12119254]
  39. J Card Fail. 1998 Sep;4(3):193-201 [PMID: 9754590]
  40. Recent Pat Cardiovasc Drug Discov. 2006 Nov;1(3):291-305 [PMID: 18221094]
  41. Eur J Heart Fail. 2004 Jan;6(1):101-7 [PMID: 15012925]
  42. Heart. 2009 Sep;95(17):1399-408 [PMID: 19342376]
  43. Am Heart J. 2003 May;145(5):904-11 [PMID: 12766752]
  44. Am Heart J. 2004 Feb;147(2):339-46 [PMID: 14760334]
  45. Clin Sci (Lond). 2006 Apr;110(4):409-25 [PMID: 16526946]
  46. Cardiovasc Res. 2007 Jan 1;73(1):10-8 [PMID: 17045979]
  47. J Cardiothorac Vasc Anesth. 2008 Jun;22(3):455-67 [PMID: 18503942]
  48. Am Heart J. 2002 Jul;144(1):23-30 [PMID: 12094184]
  49. J Appl Physiol (1985). 2000 May;88(5):1565-70 [PMID: 10797113]
  50. Circulation. 1999 Mar 9;99(9):1173-82 [PMID: 10069785]
  51. Am J Physiol Endocrinol Metab. 2009 Apr;296(4):E738-47 [PMID: 19141681]
  52. FASEB J. 2003 Apr;17(6):708-10 [PMID: 12586739]
  53. J Cardiopulm Rehabil Prev. 2007 Nov-Dec;27(6):368-75 [PMID: 18197070]
  54. J Am Coll Cardiol. 1999 Jun;33(7):1956-63 [PMID: 10362199]
  55. Arch Phys Med Rehabil. 1999 Jul;80(7):746-50 [PMID: 10414756]
  56. Circulation. 2003 Aug 5;108(5):554-9 [PMID: 12860904]
  57. Circulation. 2004 Apr 6;109(13):1615-22 [PMID: 15037527]
  58. Eur Heart J. 2002 Dec;23(23):1854-60 [PMID: 12445534]
  59. J Am Coll Cardiol. 2003 Feb 5;41(3):460-7 [PMID: 12575976]
  60. Int J Cardiol. 2006 Nov 18;113(3):364-70 [PMID: 16707174]
  61. Circulation. 1997 Sep 16;96(6):1790-7 [PMID: 9323063]
  62. Am J Physiol Heart Circ Physiol. 2000 Oct;279(4):H1999-2005 [PMID: 11009490]
  63. J Card Fail. 2009 Dec;15(10):835-42 [PMID: 19944359]
  64. J Physiol. 2006 Mar 1;571(Pt 2):253-73 [PMID: 16410283]
  65. Eur J Cardiovasc Prev Rehabil. 2005 Aug;12(4):407-14 [PMID: 16079651]
  66. Arch Intern Med. 2008 Nov 10;168(20):2194-204 [PMID: 19001195]
  67. Lancet. 1999 May 29;353(9167):1838-42 [PMID: 10359409]

Word Cloud

Created with Highcharts 10.0.0ETfailureheartbeneficialCHFfunctionenergyexercisetrainingpatientsmusclemetabolismqualitylifenowcomplimentaryunderlyingeffectsresistancecardiacskeletalcellspathophysiologyseveralconditionsincludingpartlyattributablecellStudiesshownimprovesQOLtermsreductionsymptomsmortalitydurationhospitalizationIncreasinglyachievingacceptancetherapyadditionroutineclinicalpracticechronicHowevermechanismsfarlessunderstoodneedevaluationEvidencesuggestsinducesgeneralizedmetabolicdepletionlargelyenhancesoverallHenceresearcheffortsaiminguncovertreatmentcontextimprovingendothelialcoronaryperfusiondecreasingperipheralinductionremodelingincreasingoxygenuptakesubstrateoxidationfatiguediscusscurrentevidencesuggestoxidativeintracellulartransferCurrentconceptsbenefitscongestiveHeartmyocardialnitricoxideproinflammatorycytokinesventilatory

Similar Articles

Cited By